Affiliation:
1. Kazan State Medical University
Abstract
Hemolytic-uremic syndrome is a serious problem in pediatrics and pediatric nephrology. Hemolytic-uremic syndrome is one of the leading causes of acute kidney injury with potential transformation into terminal chronic kidney disease. Currently, the endothelial dysfunction is strongly associated with changes in the serotonergic system in the pathogenesis of hemolytic-uremic syndrome. There are few studies that have revealed an increase in the blood plasma serotonin concentration in children with hemolytic-uremic syndrome, but its role in the pathogenesis of chronic kidney disease has been insufficiently studied. The progressive course of hemolytic-uremic syndrome, up to the terminal stage of renal failure, requires the search for markers of renal tissue damage as prognostically significant factors for the development of nephrosclerosis, which is of particular importance for optimizing the management of such children.
Publisher
The National Academy of Pediatric Science and Innovation
Subject
Pediatrics, Perinatology and Child Health
Reference48 articles.
1. Bulatov V.P., Makarova T.P., Samojlova N.V., Emirova H.M. Hemolytic-uremic syndrome in children. Kazan: Meditsina, 2016; 144. (in Russ.)
2. Kozlovskaya N.L., Prokopenko E.I., Emirova H.M., Serikova S.Yu. Clinical recommendations for the diagnosis and treatment of atypical hemolytic-uremic syndrome. Nefrologiya i dializ 2015; 17(3): 242–264. (in Russ.)
3. Cygin A.N., Vashurina T.V., Margieva T.V., Anan’in P.V., Mazo A.M., Pushkov A.A. et al. Federal clinical recommendations for providing assistance to children with hemolytic-uremic syndrome. Pediatricheskaya farmakologiya 2015; 12(4): 447–455. DOI: 10.15690/pf.v12i4.1427 (in Russ.)
4. Davin J.C., Gracchi V., Bouts A., Groothoff J., Strain L., Goodship T. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. Am J Kidney Dis 2010; 55(4): 708–11. DOI: 10.1053/j.ajkd.2009.08.011
5. Barbour T., Johnson S., Cohney S., Hughes P. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant 2012; 27(7): 2673–85. DOI: 10.1093/ndt/gfs279